Enfortumab vedotin-ejfv for the treatment of advanced urothelial carcinoma

Mantia, CM; Sonpavde, G

Sonpavde, G (通讯作者),Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA.;Sonpavde, G (通讯作者),Harvard Med Sch, Boston, MA 02115 USA.

EXPERT REVIEW OF ANTICANCER THERAPY, 2022; 22 (5): 449

Abstract

Introduction Metastatic urothelial carcinoma is an aggressive malignancy with a poor prognosis. Research in recent years has led to the approval of ne......

Full Text Link